In Vivo Activity of Evernimicin (SCH 27899) against Methicillin-Resistant Staphylococcus aureus in Experimental Infective Endocarditis

Currently, there exist few satisfactory alternatives to vancomycin for therapy of serious methicillin-resistant Staphylococcus aureus (MRSA) infections. We employed a rat model of aortic valve endocarditis to assess the potential efficacy of evernimicin (SCH 27899) compared with vancomycin against i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Boucher, Helen W., Thauvin-Eliopoulos, Claudie, Loebenberg, David, Eliopoulos, George M.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2001
Matèries:
Experimental Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC90262/
https://ncbi.nlm.nih.gov/pubmed/11120967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.45.1.208-211.2001
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars